A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...
Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based cancer therapeutics delivered via ...
Global proteomics and functional analyses reveal that p53-induced ZMAT3 suppresses mitochondrial respiration by inhibiting transcription of a hexokinase, uncovering a role for ZMAT3 in transcription.
How cancer cells die from chemotherapy: a new pathway. We have been treating cancer by damaging the DNA of tumor cells for over a hundred years, for example with radiation and che ...
Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of p53-based ...
Lead programme based on a first--in--class small--molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV--positive head and neck cancer -- Programme has demonstrated strong in ...
The Medal of Honor is presented to individuals whose research has fundamentally advanced cancer prevention, diagnosis, treatment, and survivorship.
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...
Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ...
A Ghanaian Scientist’s breakthrough research on fluorescent molecular probes could transform how the world detects cancer at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results